N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances
Research output: Contribution to journal › Journal article › Research › peer-review
Acromegaly is associated with hypertrophic cardiomyopathy, hypertension and subsequent congestive heart failure. Impairment of cardiac function has also been associated with growth hormone deficiency (GHD). B-type natriuretic peptides (BNPs) have emerged as strong diagnostic and prognostic risk markers. They are cardioprotective hormones that compensate heart disease by promoting natriuresis and modulation of cardiac hypertrophy in response to volume expansion and ventricular wall stretch.
| Original language | English |
|---|---|
| Journal | Clinical Endocrinology |
| Volume | 66 |
| Issue number | 5 |
| Pages (from-to) | 619-25 |
| Number of pages | 7 |
| ISSN | 0300-0664 |
| DOIs | |
| Publication status | Published - May 2007 |
- Acromegaly, Adult, Aged, Analysis of Variance, Antineoplastic Agents, Hormonal, Biological Markers, Case-Control Studies, Female, Follow-Up Studies, Growth Hormone, Humans, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor I, Male, Middle Aged, Natriuretic Peptide, Brain, Octreotide, Peptide Fragments, Peptides, Cyclic, Protein Precursors, Retrospective Studies, Somatostatin, Statistics, Nonparametric
Research areas
ID: 92190531